No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Curis Announces Additional Data From Takeaim Leukemia Study
HC Wainwright & Co. Reiterates Buy on Curis, Maintains $20 Price Target
H.C. Wainwright Maintains Curis(CRIS.US) With Buy Rating, Maintains Target Price $20
Curis Inc. Receives Buy Rating: Strong Financials and Promising Clinical Trial Progress Drive Growth Potential
Little Excitement Around Curis, Inc.'s (NASDAQ:CRIS) Revenues As Shares Take 26% Pounding
Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript Summary
Unlock the Full List